Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Nature Communications|November 29, 2023
HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasisMichael F Emmons, Richard L Bennett, Alberto Riva, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapyRichard A Morgan, Nachimuthu Chinnasamy, Daniel Abate-Daga, et al.
Breast Cancer Research and Treatment|March 13, 2019
Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapyNicholas B Figura, Victoria T Rizk, Homan Mohammadi, et al.
International Journal of Molecular Sciences|May 7, 2025
Intravenous Immunoglobulin (IVIG) for Patients with Severe Neurotoxicity Associated with Chimeric Antigen Receptor T-Cell (CAR-T) TherapySepideh Mokhtari, Justin M Asquith, Syeda Saba Kareem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2021
Single-Cell Characterization of the Immune Microenvironment of Melanoma Brain and Leptomeningeal MetastasesInna Smalley, Zhihua Chen, Manali Phadke, et al.
Neuro-Oncology|February 25, 2022
A preclinical model of patient-derived cerebrospinal fluid circulating tumor cells for experimental therapeutics in leptomeningeal disease from melanomaVincent Law, Zhihua Chen, Francesca Vena, et al.
BMC Cancer|May 16, 2021
Capecitabine and stereotactic radiation in the management of breast cancer brain metastasesMatthew N Mills, Afrin Naz, Chetna Thawani, et al.
Neuro-Oncology|April 16, 2013
Treating brain tumor-initiating cells using a combination of myxoma virus and rapamycinFranz J Zemp, Xueqing Lun, Brienne A McKenzie, et al.
Cancer Immunology Research|November 17, 2021
Identification of Immunogenic MHC Class II Human HER3 Peptides that Mediate Anti-HER3 CD4<sup>+</sup> Th1 Responses and Potential Use as a Cancer VaccineAmrita Basu, Gabriella K Albert, Sabrina Awshah, et al.
Cancer Immunology Research|March 3, 2021
Targeted Therapy Given after Anti-PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor ImmunityManali S Phadke, Zhihua Chen, Jiannong Li, et al.
Pageof 15